Exelixis, Inc.
Exelixis, Inc.
Back to Directory   


 

Exelixis' Cabozantinib Shows Encouraging Clinical Activity in Patients With Metastatic Breast Cancer

 
  Message From The Company
This information is not currently provided by Exelixis, Inc..
  Our Most Recent Webcast
SYMBOL EVENT TITLE  LISTEN DATE TIME (ET)
EXEL Exelixis, Inc. at American Society of Clinical Oncology (ASCO) 2013 Annual Meeting 2-Jun-13 7:00 PM
  Our Most Recent Annual Report
SYMBOL REPORT TITLE  DATE FORMAT
EXEL 2010 Annual Report (pdf) 19-Apr-2011